All News #Library
Rare Diseases
Disc Medicine Taps Ex-FDA Leaders to Revive Rejected Drug
17 Feb 2026 //
BIOSPACE
FDA Rejects Disc’s Rare Blood Disease Drug Amid Reports of Prasad
16 Feb 2026 //
BIOSPACE
Disc`s Rare Disease Drug Hit By FDA Rejection
14 Feb 2026 //
PRESS RELEASE
Disc Medicine Submits Bitopertin NDA For Accelerated EPP Approval
30 Sep 2025 //
GLOBENEWSWIRE
Disc blames `outsized` placebo response on mixed Pha 2 data rare blood disorder
01 Apr 2024 //
ENDPTS
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405
09 Feb 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support